Greek CEO of Pfizer says COVID-19 vaccine is more than 90% effective

·

Pharmaceutical company, Pfizer, have announced that early results from its coronavirus vaccine suggest the shots may be 90% effective at preventing COVID-19.

Pfizer and German partner, BioNTech SE, are the first drug-makers to show successful data from a large-scale clinical trial of a coronavirus vaccine, putting them on track to apply for emergency-use approval from the US Food and Drug Administration later this month.

If authorised, the number of vaccine doses will initially be limited. Many questions also remain, including how long the vaccine will provide protection.

READ MORE: Mitsotakis reassures citizens of Greece’s plan to have Covid-19 vaccine by end of December.

This October 2020 photo provided by Pfizer shows part of a “freezer farm,” a football field-sized facility for storing finished COVID-19 vaccines, under construction in Kalamazoo, Mich. Photo: Jeremy Davidson/Pfizer via AP.

However, the news provides hope that other vaccines in development against the coronavirus may also prove effective.

“Today is a great day for science and humanity,” Albert Bourlas, Pfizer’s chairman and chief executive, said in a statement.

“We are reaching this critical milestone in our vaccine development program at a time when the world needs it most with infection rates setting new records, hospitals nearing over-capacity and economies struggling to reopen.”

READ MORE: COVID-19 vaccine: Greek and Australian PM’s give mixed messages.

Greek CEO of Pfizer, Albert Bourlas.

Speaking later on CNBC, Bourlas added that the vaccine was “a light at the end of the tunnel.”

“When you realise your vaccine has 90% effectiveness, that’s overwhelming,” Mr Bourlas said.

“I am very happy but at the same time, sometimes I have tears in my eyes when I realise that this is the end of nine months, day-and-night work of so many people and how many people, billions, invested hopes on this. I never thought it would be 90%.”

READ MORE: Greek PM: “Let philotimo be our national vaccine” against coronavirus.

This May 4, 2020, file photo provided by the University of Maryland School of Medicine, shows the first patient enrolled in Pfizer’s COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore. Photo: Courtesy of University of Maryland School of Medicine via AP, File.

Pfizer said the interim analysis was conducted after 94 participants in the trial developed COVID-19, examining how many of them received the vaccine versus a placebo.

The company did not break down exactly how many of those who fell ill received the vaccine. Still, over 90% effectiveness implies that no more than 8 of the 94 people who caught COVID-19 had been given the vaccine, which was administered in two shots about three weeks apart.

The efficacy rate is well above the 50% effectiveness required by the US Food and Drug Administration for a coronavirus vaccine.

READ MORE: Australian religious leaders raise “ethical concerns” about potential COVID-19 vaccine.

Pfizer and BioNTech have a $1.95 billion contract with the US government to deliver 100 million vaccine doses beginning this year. They have also reached supply agreements with the European Union, the UK, Canada and Japan.

To save time, the companies began manufacturing the vaccine before they knew whether it would be effective. They now expect to produce up to 50 million doses or enough vaccine to protect 25 million people this year.

Pfizer said it expects to produce up to 1.3 billion doses of the vaccine in 2021.

Advertisement

Share:

KEEP UP TO DATE WITH TGH

By subscribing you accept our Terms of Service and Privacy Policy.

Advertisement

Latest News

Sydney restaurant owner Peter Papas pushes back on council speed limit cuts

Sydney restaurant owner Peter Papas has criticised a growing push by local councils to reduce speed limits across suburban streets.

Emotional memories shared at launch of ‘Finding Home’ exhibition at Bonegilla

The stories of Greek migrants to Australia came to life on June 6 at the official launch of Finding Home, a new exhibition at the Bonegilla.

Feast day of the Holy Spirit celebrated at the Holy Trinity Church in Footscray

The Feast Day of the Holy Spirit was celebrated by the faithful at the Holy Trinity Church in Footscray, Melbourne.

Kingsgrove High School’s ‘Future Links’ expo inspires students to dream big

On Friday, June 6, Kingsgrove High School (KHS) proudly hosted its fifth annual Future Links Careers Expo.

Nick Tsougranis to make emotional NRL debut for the Dragons

Nick Tsougranis will make his NRL debut for the Dragons on Thursday night as they take on rivals Cronulla in the southern Sydney derby.

You May Also Like

Poros to become third ‘green’ island of Greece

During the COP28 conference in Dubai, Kyriakos Mitostakis announced that Poros will become the third ‘green’ island of Greece.

Victorian Court increases fine to $3 million over workplace death of Michael Tsahrelias

A Victorian company has been ordered to pay a $3 million fine over the workplace manslaughter of subcontractor Michael Tsahrelias.

Stefanos Tsitsipas kicks off Wimbledon campaign with a win

Stefanos Tsitsipas fended off a valiant Taro Daniel 7-6(5), 6-4, 7-5 to progress to the second round at Wimbledon.